We are very proud to have received last year’s German Innovation Award in the “Excellence in B2B, Pharmaceuticals” category as it underlines the innovative power of our company and honours our efforts to prove the efficacy of our Bioactive Collagen Peptides (BCP^®s) in high quality scientific studies. The German Innovation Awards recognizes products and solutions from a variety of industries that distinguish themselves by their user centricity and added value. Nominated innovations are those designed to have a positive influence on life.

Supported by a new scientific study in postmenopausal women, FORTIBONE^® supplementation was shown to increase the bone mineral density (BMD) of the spine and femoral neck by 5–7%. Demonstrating a clear anabolic effect and a specific mode of action, it was judged to be a good alternative or a safe addition to existing remedies. Many current   osteoporosis treatments have an anticatabolic effect that can cause severe side-effects.

That is so important because osteoporosis has serious health implications, not just for the wellbeing of individuals, but also for the population as a whole. In fact, it’s estimated that, globally, one in three women and one in five men older than 50 will sustain an osteoporotic-induced bone fracture during their lifetime. In the EU alone, the number of these incidences is predicted to grow by 28% from 2010 to 2025, resulting in economic costs of more than €45 billion.

Further scientific studies showed that FORTIBONE^® initiates osteoblast activity to increase the production of the extracellular bone matrix, which is the essential framework for calcium mineralization and also regulates the degenerative processes that affect bones by reducing osteoclast-based protease production. It stimulates the body to build the basic components needed for a strong and stable bone structure, supporting overall bone stability and flexibility. As a result, the Bioactive Collagen Peptides (BCP^®s) in FORTIBONE^® are proven to counteract BMD loss and can help to prevent osteopenia and osteoporosis, which have become major global health problems.

Data obtained from a number of clinical trials strongly suggest that FORTIBONE^® could play a noteworthy role in bone health metabolism and the so called “downward spiral” that often begins with fractures, the subsequent lack of physical movement and the inevitable loss of independence with age. Plus, as a natural, clean label and easily digestible food product, non-allergenic FORTIBONE^® can be used in a wide variety of foods, such as dairy products, functional foods and food supplements.

Want to know more about GELITA’s wide range of bone and joint health solutions for both humans and animals? Please don’t hesitate to contact us.